Authors
Loading...
Single-cell transcriptomic profiling reveals metabolic reprogramming and cellular heterogeneity across Acinetobacter baumannii biofilm development, highlighting potential therapeutic vulnerabilities.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: